» Articles » PMID: 36612210

Epimutations and Their Effect on Chromatin Organization: Exciting Avenues for Cancer Treatment

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Jan 8
PMID 36612210
Authors
Affiliations
Soon will be listed here.
Abstract

The three-dimensional architecture of genomes is complex. It is organized as fibers, loops, and domains that form high-order structures. By using different chromosome conformation techniques, the complex relationship between transcription and genome organization in the three-dimensional organization of genomes has been deciphered. Epigenetic changes, such as DNA methylation and histone modification, are the hallmark of cancers. Tumor initiation, progression, and metastasis are linked to these epigenetic modifications. Epigenetic inhibitors can reverse these altered modifications. A number of epigenetic inhibitors have been approved by FDA that target DNA methylation and histone modification. This review discusses the techniques involved in studying the three-dimensional organization of genomes, DNA methylation and histone modification, epigenetic deregulation in cancer, and epigenetic therapies targeting the tumor.

Citing Articles

H3K27me3 Loss in Central Nervous System Tumors: Diagnostic, Prognostic, and Therapeutic Implications.

Angelico G, Mazzucchelli M, Attanasio G, Tinnirello G, Farina J, Zanelli M Cancers (Basel). 2024; 16(20).

PMID: 39456545 PMC: 11506073. DOI: 10.3390/cancers16203451.


An oncogene regulating chromatin favors response to immunotherapy: Oncogene CHAF1A and immunotherapy outcomes.

Ying L, Hu Z, Lu Y, Tao Q, Xiong F, Shu Y Oncoimmunology. 2024; 13(1):2303195.

PMID: 38235318 PMC: 10793680. DOI: 10.1080/2162402X.2024.2303195.

References
1.
Sugino N, Kawahara M, Tatsumi G, Kanai A, Matsui H, Yamamoto R . A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers. Leukemia. 2017; 31(11):2303-2314. DOI: 10.1038/leu.2017.59. View

2.
Knipstein J, Gore L . Entinostat for treatment of solid tumors and hematologic malignancies. Expert Opin Investig Drugs. 2011; 20(10):1455-67. DOI: 10.1517/13543784.2011.613822. View

3.
Hyun K, Jeon J, Park K, Kim J . Writing, erasing and reading histone lysine methylations. Exp Mol Med. 2017; 49(4):e324. PMC: 6130214. DOI: 10.1038/emm.2017.11. View

4.
Zentner G, Henikoff S . Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol. 2013; 20(3):259-66. DOI: 10.1038/nsmb.2470. View

5.
Baylin S, Jones P . A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011; 11(10):726-34. PMC: 3307543. DOI: 10.1038/nrc3130. View